Effect of remdesivir on mortality in patients with COVID‐19: A meta‐analysis of randomized control trials
2020; Wiley; Volume: 93; Issue: 4 Linguagem: Inglês
10.1002/jmv.26638
ISSN1096-9071
AutoresChia Siang Kow, Mamoon A. Aldeyab, Syed Shahzad Hasan,
Tópico(s)Long-Term Effects of COVID-19
ResumoJournal of Medical VirologyVolume 93, Issue 4 p. 1860-1861 LETTER TO THE EDITOR Effect of remdesivir on mortality in patients with COVID-19: A meta-analysis of randomized control trials Chia Siang Kow, Corresponding Author Chia Siang Kow [email protected] orcid.org/0000-0002-8186-2926 School of Postgraduate Studies, International Medical University, Kuala Lumpur, Malaysia Correspondence Chia Siang Kow, Federal Territory of Kuala Lumpur, 126, Jln Jalil Perkasa 19, Bukit Jalil, Kuala Lumpur 57000, Malaysia. Email: [email protected]Search for more papers by this authorMamoon Aldeyab, Mamoon Aldeyab School of Applied Sciences, University of Huddersfield, Huddersfield, UKSearch for more papers by this authorSyed Shahzad Hasan, Syed Shahzad Hasan orcid.org/0000-0002-4058-2215 School of Applied Sciences, University of Huddersfield, Huddersfield, UK School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, AustraliaSearch for more papers by this author Chia Siang Kow, Corresponding Author Chia Siang Kow [email protected] orcid.org/0000-0002-8186-2926 School of Postgraduate Studies, International Medical University, Kuala Lumpur, Malaysia Correspondence Chia Siang Kow, Federal Territory of Kuala Lumpur, 126, Jln Jalil Perkasa 19, Bukit Jalil, Kuala Lumpur 57000, Malaysia. Email: [email protected]Search for more papers by this authorMamoon Aldeyab, Mamoon Aldeyab School of Applied Sciences, University of Huddersfield, Huddersfield, UKSearch for more papers by this authorSyed Shahzad Hasan, Syed Shahzad Hasan orcid.org/0000-0002-4058-2215 School of Applied Sciences, University of Huddersfield, Huddersfield, UK School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, AustraliaSearch for more papers by this author First published: 29 October 2020 https://doi.org/10.1002/jmv.26638Citations: 9Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. REFERENCES 1Beigel JH, Tomashek KM, Dodd LE, et al. Remdesivir for the treatment of COVID-19—preliminary report. N Engl J Med. 2020. 10.1056/NEJMoa2007764 Web of Science®Google Scholar 2Goldman JD, Lye DCB, Hui DS, et al. Remdesivir for 5 or 10 days in patients with severe COVID-19. N Engl J Med. 2020. 10.1056/NEJMoa2015301 Web of Science®Google Scholar 3Spinner CD, Gottlieb RL, Criner GJ, et al. Effect of remdesivir vs standard care on clinical status at 11 days in patients with moderate COVID-19: a randomized clinical trial. JAMA. 2020:e2016349. Web of Science®Google Scholar 4Wang Y, Zhang D, Du G, et al. Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet. 2020; 395(10236): 1569-1578. 10.1016/S0140-6736(20)31022-9 CASPubMedWeb of Science®Google Scholar 5Jiang Y, Chen D, Cai D, Yi Y, Jiang S. Effectiveness of remdesivir for the treatment of hospitalized COVID-19 persons: a network meta-analysis. J Med Virol. 2020. https://doi.org/10.1002/jmv.26443 Web of Science®Google Scholar Citing Literature Volume93, Issue4Special Issue on New coronavirus (2019‐nCoV or SARS‐CoV‐2) and the outbreak of the respiratory illness (COVID‐19): Part‐XIApril 2021Pages 1860-1861 ReferencesRelatedInformation
Referência(s)